High-dose carboplatin, etoposide and melphalan (CEM) with peripheral blood progenitor cell support as late intensification for high-risk cancer: non-haematological, haematological...

por Benedetti Panici, P., Pierelli, L., Scambia, G., Foddai, M. L., Salerno, M. G., Menichella, G., Vittori, M., Maneschi, F., Caracussi, U., Serafini, R., Leone, G., Mancuso, S.
Publicado 1997